Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 12, 2022
Reporting Period: First quarter ended March 31, 2022
Context: This filing serves to announce the issuance of a press release detailing the company's financial results for the first quarter of 2022. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended March 31, 2022, were announced.
Guidance, Outlook, and Risks
The source text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These elements are presumed to be contained within the referenced press release (Exhibit 99.1), which is not included in the input.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 12, 2022) for actual Q1 2022 financial figures.
- Verify the company's cash position and burn rate given the lack of specific liquidity data in this summary.
- Check for any updated operational milestones or product development status mentioned in the full press release.
- Confirm the trading symbol (ACHV) and exchange (NASDAQ Capital Market) for current market data.